Muhammad Shoaib

Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study

Marc Decramer, Kenneth R. Chapman, Ronald Dahl et al. · The Lancet Respiratory Medicine · 2013 · 272 citations

Health Policy, Indacaterol Versus Tiotropium, Advanced Lung Disease +4

A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer

Patricia Pautier, Ignace Vergote, Florence Joly et al. · International Journal of Gynecological Cancer · 2016 · 38 citations · Full text

A phase II study of bemcentinib (BGB324), a first-in-class highly selective AXL inhibitor, with pembrolizumab in pts with advanced NSCLC: OS for stage I and preliminary stage II efficacy.

Enriqueta Felip, Paal Brunsvig, Núria Viñolas et al. · Journal of Clinical Oncology · 2019 · 28 citations

Selective Axl Inhibitor, Immunology, Pathology +19

Pharmacological effect of Rubus ulmifolius Schott as antihyperglycemic and antihyperlipidemic on streptozotocin (STZ)-induced albino mice

Khalil Akhtar, Syed Wadood Ali Shah, Assar Ali Shah et al. · Applied Biological Chemistry · 2017 · 15 citations · Full text

Molecular Pharmacology, Albino Mice, Pharmacological Effect +15

Initial results of efficacy and safety of Sofosbuviramong Pakistani Population: A real life trial Hepatitis Eradication Accuracy Trial of Sofosbuvir (HEATS)

Zahid Azam, Muhammad Shoaib, Masood Javed et al. · Pakistan Journal of Medical Sciences · 2017 · 13 citations · Full text